FMO2 alleviates doxorubicin-induced cardiac injury via promoting XLF-dependent DNA repair

1 September 2025 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Basic bombshells in heart failure Cardiotoxicity of Drugs and Other Therapies ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology